EGFR and neoplasm: Secondly, in antibody-treated A431 cell xenograft tumor tissues, Ame55 has increased inhibition of the EGFR pathway, including total EGFR, pEGFR Y1068, and its downstream pAKT and pERK1/2, but the inhibition effect is still less than that of cetuximab.